{"id":"https://openalex.org/W1521544644","doi":null,"title":"Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts.","display_name":"Chronotherapy and chronotoxicity of the cyclooxygenase-2 inhibitor, celecoxib, in athymic mice bearing human breast cancer xenografts.","publication_year":2001,"publication_date":"2001-10-01","ids":{"openalex":"https://openalex.org/W1521544644","mag":"1521544644","pmid":"https://pubmed.ncbi.nlm.nih.gov/11595712"},"language":"en","primary_location":{"id":"pmid:11595712","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11595712","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110227609","display_name":"Rosalyn D. Blumenthal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R D Blumenthal","raw_affiliation_strings":["Garden State Cancer Center, Belleville, New Jersey 07109, USA. rblumenthal.gscancer@att.net"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Garden State Cancer Center, Belleville, New Jersey 07109, USA. rblumenthal.gscancer@att.net","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058101713","display_name":"Chris Waskewich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Waskewich","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D M Goldenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013954632","display_name":"Walter Lew","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"W Lew","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055799863","display_name":"Christine Flefleh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Flefleh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"J Burton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Burton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7275,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.83937008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"7","issue":"10","first_page":"3178","last_page":"85"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10342","display_name":"Circadian rhythm and melatonin","score":0.7484999895095825,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10342","display_name":"Circadian rhythm and melatonin","score":0.7484999895095825,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.23849999904632568,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12626","display_name":"Cancer, Stress, Anesthesia, and Immune Response","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":0.9580000042915344},{"id":"https://openalex.org/keywords/chronotherapy","display_name":"chronotherapy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/chronotoxicity","display_name":"chronotoxicity","score":0.9909999966621399},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7929999828338623},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.7160000205039978},{"id":"https://openalex.org/keywords/circadian-rhythm","display_name":"circadian rhythm","score":0.7260000109672546},{"id":"https://openalex.org/keywords/timing-of-drug-administration","display_name":"timing of drug administration","score":0.746999979019165},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.6980000138282776},{"id":"https://openalex.org/keywords/cox-2-expression","display_name":"COX-2 expression","score":0.8560000061988831},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.8840000033378601},{"id":"https://openalex.org/keywords/mda-mb-468-cells","display_name":"MDA-MB-468","score":0.9430000185966492},{"id":"https://openalex.org/keywords/nude-mice","display_name":"nude mice","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.8551000356674194},{"id":"https://openalex.org/C2779910239","wikidata":"https://www.wikidata.org/wiki/Q7539765","display_name":"Chronotherapy (sleep phase)","level":3,"score":0.7081743478775024},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6535107493400574},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6457861661911011},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5948312282562256},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4327625334262848},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.41407814621925354},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.41305768489837646},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4118247330188751},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3941463232040405},{"id":"https://openalex.org/C121446783","wikidata":"https://www.wikidata.org/wiki/Q208353","display_name":"Circadian rhythm","level":2,"score":0.26747095584869385},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2334473431110382},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.123379647731781},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001219","descriptor_name":"Aspartate Aminotransferases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001219","descriptor_name":"Aspartate Aminotransferases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001663","descriptor_name":"Bilirubin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001806","descriptor_name":"Blood Urea Nitrogen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011451","descriptor_name":"Prostaglandin-Endoperoxide Synthases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012334","descriptor_name":"RNA, Neoplasm","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012334","descriptor_name":"RNA, Neoplasm","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014527","descriptor_name":"Uric Acid","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019454","descriptor_name":"Chronotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11595712","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11595712","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"mag:1521544644","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11595712","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4002363237","display_name":"RADIOIMMUNOTHERAPY OF CANCER","funder_award_id":"P01CA079857","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6361495416","display_name":"RADIOIMMUNOTHERAPY AND TUMOR VASCULAR PHYSIOLOGY","funder_award_id":"R01CA060764","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W116477296","https://openalex.org/W155792476","https://openalex.org/W1905047988","https://openalex.org/W1955690499","https://openalex.org/W1962449772","https://openalex.org/W1964246992","https://openalex.org/W1965422635","https://openalex.org/W1966827463","https://openalex.org/W1967893391","https://openalex.org/W1980975664","https://openalex.org/W1986449047","https://openalex.org/W1989230609","https://openalex.org/W1995466607","https://openalex.org/W2001476006","https://openalex.org/W2004644919","https://openalex.org/W2022454304","https://openalex.org/W2023040133","https://openalex.org/W2036129060","https://openalex.org/W2037745595","https://openalex.org/W2043707891","https://openalex.org/W2048925802","https://openalex.org/W2053627417","https://openalex.org/W2062813587","https://openalex.org/W2078422697","https://openalex.org/W2091661826","https://openalex.org/W2108346917","https://openalex.org/W2120850551","https://openalex.org/W2127558096","https://openalex.org/W2128390521","https://openalex.org/W2136501106","https://openalex.org/W2138178697","https://openalex.org/W2139199952","https://openalex.org/W2143296984","https://openalex.org/W2147753291","https://openalex.org/W2148122132","https://openalex.org/W2150966393","https://openalex.org/W2156470937","https://openalex.org/W2162313061","https://openalex.org/W2163462883","https://openalex.org/W2242318210","https://openalex.org/W2336169581","https://openalex.org/W2410497314","https://openalex.org/W2422214872","https://openalex.org/W2464920985"],"related_works":["https://openalex.org/W2135663587","https://openalex.org/W2373976089","https://openalex.org/W2135794748","https://openalex.org/W2363909495","https://openalex.org/W2350656554","https://openalex.org/W2368475037","https://openalex.org/W2384280119","https://openalex.org/W1867715023","https://openalex.org/W2160843447","https://openalex.org/W2071504676"],"abstract_inverted_index":{"PURPOSE:":[0],"Inhibition":[1],"of":[2,13,39,63,67,71,77,175],"the":[3,60,135,154,160,170,188,197,260,286,289],"enzyme":[4],"cyclooxygenase":[5],"with":[6,81],"celecoxib":[7,72,176],"is":[8,44],"cytotoxic":[9],"in":[10,47],"a":[11,37,149],"variety":[12],"solid":[14],"tumor":[15,119,242],"cell":[16],"lines.":[17],"Previous":[18],"work":[19],"has":[20,28],"shown":[21],"that":[22,42,184,266],"by":[23],"charting":[24],"circadian":[25],"rhythms,":[26],"it":[27,43],"been":[29],"possible":[30],"to":[31,35,54,73,83,104,214,219,237,259,283],"find":[32],"optimal":[33,75],"times":[34],"deliver":[36],"dose":[38,151,173,273],"drug,":[40],"such":[41],"most":[45],"efficacious":[46],"killing":[48],"cancer":[49],"cells":[50],"and":[51,66,118,134,158,166,240,275],"least":[52,136],"harmful":[53],"normal":[55],"tissues.":[56],"Therefore,":[57],"we":[58,182],"examined":[59],"time":[61,76],"dependence":[62],"toxicity":[64],"(chronotoxicity)":[65],"antitumor":[68],"effects":[69],"(chronotherapy)":[70],"determine":[74],"day":[78],"for":[79,92,179],"dosing":[80,208,229,247],"respect":[82],"light-dark":[84],"cycles.":[85],"EXPERIMENTAL":[86],"DESIGN:":[87],"Celecoxib":[88],"was":[89,129,177,190,199,205,209,226,230,244,248,268,280],"administered":[90,274],"i.p.":[91],"10":[93,201],"days":[94,96,99,102],"(5":[95,217],"on,":[97],"2":[98],"off,":[100],"5":[101],"on)":[103],"nude":[105],"mice":[106],"bearing":[107],"s.c.":[108],"breast":[109,162],"xenografts.":[110],"Body":[111],"weight,":[112],"peripheral":[113],"blood":[114],"cells,":[115],"clinical":[116],"chemistry,":[117],"growth":[120,243,257],"were":[121],"monitored.":[122],"RESULTS:":[123],"The":[124],"highest":[125],"tolerance":[126],"(100%":[127],"survival)":[128],"found":[130,183],"at":[131,138,148,185,194,211,232,250,262],"7":[132,215,238],"HALO":[133,156,213,216,234,252,264],"occurred":[137],"17":[139,251],"h":[140],"after":[141],"light":[142],"onset":[143],"(HALO;":[144],"10%":[145],"survival).":[146],"Chronotherapy":[147],"20-mg/kg":[150],"varied":[152],"between":[153,159,272],"seven":[155],"evaluated":[157],"three":[161],"tumors":[163],"(MCF-7,":[164],"ZR-75-30,":[165],"MDA-MB-468)":[167],"studied.":[168],"When":[169],"maximum":[171],"tolerated":[172],"(MTD)":[174],"optimized":[178],"each":[180,263],"HALO,":[181,187],"7-10":[186],"MTD":[189,198,261],"25":[191],"mg/kg,":[192],"whereas":[193,222],"17-20":[195],"HALO;":[196],"only":[200],"mg/kg.":[202],"Tumor":[203,256],"regression":[204],"observed":[206,227],"when":[207,228,246],"done":[210,231,249],"23":[212],"a.m.":[218],"1":[220],"p.m.),":[221,239],"no":[223,269],"therapeutic":[224,276],"response":[225,258],"10-13":[233],"(4":[235],"p.m.":[236],"rapid":[241],"noted":[245],"(11":[253],"p.m.).":[254],"CONCLUSIONS:":[255],"revealed":[265],"there":[267],"clear":[270],"relationship":[271],"response.":[277],"COX-2":[278],"expression":[279],"not":[281],"able":[282],"explain":[284],"either":[285],"chronotherapy":[287],"or":[288],"chronotoxicity":[290],"results":[291],"obtained.":[292]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}